Current Assets

Cash, Cash Equivalents, and Marketable Securities

Raymond James Financial Cash, Cash Equivalents, and Marketable Securities decreased by 1.3% to $5.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.7%, from $6.67B to $5.55B. Over 2 years (FY 2020 to FY 2025), Cash, Cash Equivalents, and Marketable Securities shows a downward trend with a -11.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ1 2016
Last reportedQ2 2026May 6, 2026
Metric ID: cash_equivalents_marketable_securities_total

Historical Data

8 periods
 Q3 '21Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Value$8.19B$7.83B$6.98B$6.67B$6.19B$5.98B$5.63B$5.55B
QoQ Change-4.5%-10.8%-4.5%-7.2%-3.3%-5.9%-1.3%
YoY Change-23.6%-19.4%-16.7%
Range$5.55B$8.19B
CAGR-19.9%
Avg YoY Growth-19.9%
Median YoY Growth-19.4%
Current Streak7+ quarters decline

Frequently Asked Questions

What is Raymond James Financial's cash, cash equivalents, and marketable securities?
Raymond James Financial (RJF) reported cash, cash equivalents, and marketable securities of $5.55B in Q1 2026.
How has Raymond James Financial's cash, cash equivalents, and marketable securities changed year-over-year?
Raymond James Financial's cash, cash equivalents, and marketable securities decreased by 16.7% year-over-year, from $6.67B to $5.55B.
What is the long-term trend for Raymond James Financial's cash, cash equivalents, and marketable securities?
Over 2 years (2020 to 2025), Raymond James Financial's cash, cash equivalents, and marketable securities has grown at a -11.6% compound annual growth rate (CAGR), from $7.65B to $5.98B.